Absorbing citywide patient surge during Hurricane Sandy: a case study in accommodating multiple hospital evacuations AA Adalja, M Watson, N Bouri, K Minton, RC Morhard, ES Toner Annals of emergency medicine 64 (1), 66-73. e1, 2014 | 103 | 2014 |
Global catastrophic biological risks: toward a working definition M Schoch-Spana, A Cicero, A Adalja, G Gronvall, T Kirk Sell, D Meyer, ... Health security 15 (4), 323-328, 2017 | 83 | 2017 |
Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations KJ Rambhia, M Watson, TK Sell, R Waldhorn, E Toner Biosecurity and bioterrorism: biodefense strategy, practice, and science 8 …, 2010 | 78 | 2010 |
Interim framework for COVID-19 vaccine allocation and distribution in the United States E Toner, A Barnill, C Krubiner, J Bernstein, L Privor-Dumm, M Watson, ... Baltimore: Johns Hopkins Center for Health Security, 2020 | 51 | 2020 |
Characteristics of microbes most likely to cause pandemics and global catastrophes AA Adalja, M Watson, ES Toner, A Cicero, TV Inglesby Global catastrophic biological risks, 1-20, 2019 | 50 | 2019 |
Public health preparedness funding: key programs and trends from 2001 to 2017 CR Watson, M Watson, TK Sell American journal of public health 107 (S2), S165-S167, 2017 | 47 | 2017 |
Federal agency biodefense funding, FY2013-FY2014 TK Sell, M Watson Biosecurity and bioterrorism: Biodefense strategy, practice, and science 11 …, 2013 | 45 | 2013 |
A community checklist for health sector resilience informed by Hurricane Sandy ES Toner, M McGinty, M Schoch-Spana, DA Rose, M Watson, E Echols, ... Health security 15 (1), 53-69, 2017 | 36 | 2017 |
Enabling emergency mass vaccination: innovations in manufacturing and administration during a pandemic D Hosangadi, KL Warmbrod, EK Martin, A Adalja, A Cicero, T Inglesby, ... Vaccine 38 (26), 4167-4169, 2020 | 34 | 2020 |
Assessing the bioweapons threat C Boddie, M Watson, G Ackerman, GK Gronvall Science 349 (6250), 792-793, 2015 | 34 | 2015 |
The characteristics of pandemic pathogens AA Adalja, M Watson, ES Toner, A Cicero, TV Inglesby Johns Hopkins Center for Health Security: Baltimore, MD, USA, 28, 2018 | 32 | 2018 |
Federal funding for health security in FY2016 C Boddie, TK Sell, M Watson Health security 13 (3), 186-206, 2015 | 25 | 2015 |
Building the global vaccine manufacturing capacity needed to respond to pandemics TK Sell, D Gastfriend, M Watson, C Watson, L Richardson, A Cicero, ... Vaccine 39 (12), 1667, 2021 | 21 | 2021 |
A conceptual approach to improving care in pandemics and beyond: severe lung injury centers AA Adalja, M Watson, RE Waldhorn, ES Toner Journal of Critical Care 28 (3), 318. e9-318. e15, 2013 | 20 | 2013 |
Federal funding for health security in FY2015 C Boddie, TK Sell, M Watson Biosecurity and bioterrorism: biodefense strategy, practice, and science 12 …, 2014 | 17 | 2014 |
Federal funding for health security in FY2019 C Watson, M Watson, D Gastfriend, TK Sell Health security 16 (5), 281-303, 2018 | 16 | 2018 |
Clade X: a pandemic exercise C Watson, ES Toner, MP Shearer, C Rivers, D Meyer, C Hurtado, ... Health security 17 (5), 410-417, 2019 | 14 | 2019 |
Vaccine platforms: state of the field and looming challenges AA Adalja, M Watson, A Cicero, T Inglesby CHS: Johns Hopkins Center for Health Security, 2019 | 14 | 2019 |
Expert views on biological threat characterization for the US Government: a Delphi study CR Watson, MC Watson, G Ackerman, GK Gronvall Risk Analysis 37 (12), 2389-2404, 2017 | 14 | 2017 |
Federal funding for health security in FY2017 C Boddie, M Watson, TK Sell Health security 14 (5), 284-304, 2016 | 14 | 2016 |